Bank Of America Corp Pear Therapeutics, Inc. Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.21 - $1.24 $3,960 - $23,387	18,861 Added 38.24%	68,190 $17,000
Q4 2022 Feb 10, 2023	BUY	$0.99 - $2.91 $42,624 - $125,290	43,055 Added 686.24%	49,329 $58,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $2.27 $814 - $14,223	6,266 Added 78325.0%	6,274 $13,000
Q2 2022 Aug 12, 2022	SELL	$1.54 - $6.48 $35,951 - $151,275	-23,345 Reduced 99.97%	8 $0
Q1 2022 May 16, 2022	BUY	$3.67 - $7.63 $85,705 - $178,183	23,353 New	23,353 $118,000

23M

Ticker PEAR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 138,768,992
Market Cap $1.39M
Description
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.